| IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma | American journal of clinical pathology |  | | 2010 | 526 | 0 |
|
| Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer | Journal of clinical pathology | | | 2009 | 533 | 0 |
|
| 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis | European journal of surgical oncology | | | 2009 | 493 | 0 |
|
| Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance | Gynecologic oncology | | | 2009 | 594 | 0 |
|
| Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas | European journal of cancer | | | 2008 | 586 | 0 |
|
| No association of NAD(P)H quinone oxidoreductase 1 expression with p53 expression or tumour outcome in patients with superficial and minimally invasive urothelial bladder cancers | BJU international | | | 2008 | 469 | 0 |
|
| The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon | International journal of gynecological cancer | | | 2008 | 646 | 2 |
|
| Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma | Cancer epidemiology, biomarkers & prevention | | | 2008 | 609 | 0 |
|
| Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma | American journal of clinical pathology | | | 2008 | 574 | 0 |
|
| Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings | International journal of gynecological pathology | | | 2008 | 569 | 0 |
|
| Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis | Journal of clinical pathology | | | 2007 | 563 | 0 |
|
| Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy | Journal of clinical pathology | | | 2007 | 619 | 0 |
|
| Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness | Blood |  | | 2007 | 227 | 293 |
|
| Clinical and Pathological Predictive Factors in Women with Adult-type Granulosa Cell Tumor of the Ovary | International journal of gynecological pathology | | | 2007 | 581 | 0 |
|
| Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique | Histopathology | | | 2007 | 652 | 0 |
|
| Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis | BJU international | | | 2007 | 555 | 0 |
|
| Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody | Journal of clinical pathology | | | 2007 | 535 | 0 |
|
| Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up | European journal of surgical oncology | | | 2006 | 610 | 0 |
|
| Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies | Histopathology | | | 2006 | 619 | 0 |
|
| FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer | European journal of surgical oncology | | | 2006 | 579 | 0 |
|
| EB-D fibronectin expression in squamous cell carcinoma of the head and neck | Oral oncology | | | 2005 | 648 | 727 |
|
| Mucoepidermoid carcinoma of Stensen's duct: a case report and review of the literature | Head & neck | | | 2005 | 595 | 966 |
|
| Human achaete-scute Homologue (hASH1) mRNA Level as a Diagnostic Marker to Distinguish Esthesioneuroblastoma From Poorly Differentiated Tumors Arising in the Sinonasal Tract | American journal of clinical pathology | | | 2004 | 689 | 632 |
|
| Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck | British journal of cancer | | | 2004 | 635 | 329 |
|
| Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression | Cancer | | | 2003 | 585 | 298 |
|
| Value of immunohistochemistry in staging T1 urothelial bladder carcinoma | European urology | | | 2002 | 544 | 1 |
|
